Supplementary Figure 7 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Supplemental Figure 7 shows PDL1 (CD274) Expression, PD1 (PDCD1) Expression, and CTLA4 Expression by UROMOL Subclasses in MSK and UNC cohorts and RFS (by high, medium, low tertiles) in MSK, UROMOL, & Northwestern Cohorts.